Ligand validation:8P5G

XBJ: 4-FLUORO-2-(4-{[(3S,4R)-4-(1-HYDROXY-1-METHYLETHYL)PYRROLIDIN-3-YL]AMINO}-6,7-DIMETHOXYQUINAZOLIN-2-YL)PHENOL

XBJ is a Ligand Of Interest in 8P5G designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8P5G_XBJ_A_301	73%	58%	0.135	0.962	0.7	0.91	-	2	1	0	100%	1
8P5G_XBJ_B_301	54%	58%	0.168	0.933	0.72	0.9	-	2	1	0	100%	1
8P5H_XBJ_A_301	81%	55%	0.12	0.972	0.73	1	-	2	0	0	100%	1
2XBJ_XBJ_A_1513	56%	1%	0.167	0.941	4.52	2.74	17	16	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.